New phase I clinical trial : antibacterial properties of silicon incorporated with quaternary ammonium polyethylenimine nanoparticles


The Hadassah Medical Organization plan to start in January 2010 a phase I clinical trial entitled “Antibacterial properties of silicon incorporated with quaternary ammonium polyethylenimine nanoparticles” now registered in the Clinicaltrials.gov database under reference NCT01007240. According to this page, “the aim of this study is to evaluate the antibacterial activity of crosslinked quaternary ammonium polyethylenimine (PEI) nanoparticles incorporated at 1-2% w/w in a commercial soft liner material when compared to the commercial soft liner material“.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: